KIDNEY MEDULLARY CARCINOMA
Clinical trials for KIDNEY MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new KIDNEY MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for KIDNEY MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat drug combo against Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…
Matched conditions: KIDNEY MEDULLARY CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New immune attack on rare, aggressive cancers
Disease control OngoingThis study is testing a combination of two immunotherapy drugs, tiragolumab and atezolizumab, for children and adults with rare, aggressive cancers that have come back or stopped responding to standard treatments. These cancers are missing specific genes (SMARCB1 or SMARCA4). The…
Matched conditions: KIDNEY MEDULLARY CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Targeted radiation joins fight against bone pain in advanced kidney cancer
Disease control OngoingThis study is for people with advanced kidney cancer that has spread to their bones. It tests if adding a radioactive drug (radium-223) to a standard cancer pill (cabozantinib) works better than the pill alone. The main goal is to see if the combination can delay bone-related pro…
Matched conditions: KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC